Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher Scientific, Genialis Ink Comarketing Agreement for RNA-Seq Data Analysis

NEW YORK – Genialis today announced a comarketing agreement with Thermo Fisher Scientific on data analysis for RNA sequencing.

Under the terms of the agreement, the partners will integrate Thermo Fisher's Invitrogen Collibri Stranded RNA Library Prep Kit for Illumina next-generation sequencing systems with the Genialis Expressions analysis software. The integrated workflow could ease the data-analysis bottleneck for RNA-seq, allowing "for more streamlined processing of … data sets for applications such as biomarker discovery," the firms said in a statement.

Financial and other terms of the deal were not disclosed.

"Genialis is a leader in providing industrial-strength analytics to pharma, biopharma, and large sequencing centers. Through our collaboration, data analysis will now be as rapid as the library preparation, easing the barriers to high-throughput sequencing to advance science for all," Raymond Mercier, Thermo Fisher VP and general manager of molecular biology, said in a statement.

Houston-based Genialis has also partnered with Roche to integrate its gene expression analysis software with KAPA RNA-seq library kits.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.